The PayPal Presidency Pt. I: Biotech and Biosurveillance with Max Jones
Unlimited Hangout with Whitney Webb
00:00
Deregulation and Surveillance in Biotech
This chapter explores the controversial push for biotechnology deregulation, particularly focusing on a public health advocate's stance against efficacy tests in drug development. It raises ethical concerns over the use of real-world data for commercial gains, including the manipulation of drug pricing and the exploitation of patient populations. The discussion ultimately highlights the intertwining of healthcare, surveillance, and corporate interests, warning of potential Orwellian scenarios.
Transcript
Play full episode
